Growth Metrics

Resmed (RMD) Treasury Shares (2016 - 2025)

Historic Treasury Shares for Resmed (RMD) over the last 16 years, with Q4 2025 value amounting to $2.4 billion.

  • Resmed's Treasury Shares rose 2644.74% to $2.4 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $2.4 billion, marking a year-over-year increase of 2644.74%. This contributed to the annual value of $2.1 billion for FY2025, which is 1691.93% up from last year.
  • As of Q4 2025, Resmed's Treasury Shares stood at $45.2 million, which was up 453.7% from $44.4 million recorded in Q3 2025.
  • Resmed's Treasury Shares' 5-year high stood at $45.2 million during Q4 2025, with a 5-year trough of $41.8 million in Q2 2021.
  • Moreover, its 5-year median value for Treasury Shares was $41.8 million (2021), whereas its average is $42.5 million.
  • As far as peak fluctuations go, Resmed's Treasury Shares changed by 0.0% in 2021, and later skyrocketed by 2644.74% in 2025.
  • Quarter analysis of 5 years shows Resmed's Treasury Shares stood at $1.6 billion in 2021, then changed by 0.0% to $1.6 billion in 2022, then rose by 3.08% to $1.7 billion in 2023, then increased by 13.45% to $1.9 billion in 2024, then increased by 26.45% to $2.4 billion in 2025.
  • Its Treasury Shares was $2.4 billion in Q4 2025, compared to $2.2 billion in Q3 2025 and $2.1 billion in Q2 2025.